Accès à distance ? S'identifier sur le proxy UCLouvain
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Onglets principaux
| Type de document | Article de périodique (Journal article) – Article de recherche |
|---|---|
| Type d'accès | Accès restreint |
| Année de publication | 2009 |
| Langue | Anglais |
| Information sur le périodique | "Cerebrovascular Diseases" - Vol. 27, no.5, p. 509-18 (2009) |
| Peer reviewed | oui |
| Editeur | S.Karger AG ((Switzerland) Basel) |
| issn | 1015-9770 |
| e-issn | 1421-9786 |
| Statut de la publication | Publié |
| Affiliations |
UCL
- (MGD) Service de neurologie UCL - MD/NOPS - Département de neurologie et de psychiatrie |
| MESH Subject | Aged ; International Cooperation ; Ischemic Attack, Transient ; Male ; Middle Aged ; Naphthalenes ; Platelet Aggregation Inhibitors ; Propionates ; Receptors, Thromboxane ; Stroke ; Treatment Outcome ; Aged, 80 and over ; Aspirin ; Cardiovascular Diseases ; Dose-Response Relationship, Drug ; Double-Blind Method ; Endpoint Determination ; Female ; Humans |
| Liens |
| Référence bibliographique | Bousser, M G ; Amarenco, P ; Chamorro, A ; Fisher, M ; Ford, I ; et. al. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.. In: Cerebrovascular Diseases, Vol. 27, no.5, p. 509-18 (2009) |
|---|---|
| Permalien | http://hdl.handle.net/2078.1/132703 |